27
Sofinnova BioEquities Enhanced Master Fund, LP updates its Form D — $41.5M sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $41.5M · MENLO PARK, CA · filed 2025-10-10
3(c)(7) — qualified purchasers
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
| -- Sofinnova BioEquities GP LLC | General Partner |
| -- Sofinnova Investments, Inc. | Investment Manager |
Signed by Jim Brody, Chief Compliance Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.